FindTrial
Sign In

A multicenter prospective randomized controlled trial of the effectiveness of compound probiotics on mild-severe antibiotic associated diarrhea with liver diseases

A multicenter prospective randomized controlled trial of the effectiveness of compound probiotics on mild-severe antibiotic associated diarrhea with liver diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037487
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-08-20
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antibiotic associated diarrhea

Interventions

Experimental group:compound probiotics
Control Group:Enteropoiesis

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 65 years; 2. admitted by liver diseases; 3. diagnosed of mild-severe antibiotic associated diarrhea.

Exclusion criteria

Exclusion criteria: 1. Diagnosed of clostridium difficile-associated diarrhea; 2. Diagnosed of colorectal cancer; 3. Treatment with immunosuppressants; 4. Nasal feeding or parenteral nutrition; 5. Other conditions that not allowed to be admitted.

Design outcomes

Primary

MeasureTime frame
diarrhea;frequency of defecation;—

Countries

China

Contacts

Public ContactJing Zhang

Beijing Youan Hospital, Capital Medical University

drzhangjing@163.com+86 13391859683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026